Madrigal Pharmaceuticals, Inc.

MDGL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001157601

SEC filings (opens in a new tab)

In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Madrigal Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of MDGL: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	133	3	144	+14
Shares	11.0M	7.08K	12.0M	+983.8K (+9.0%)
Value	$876.5M	$565.0K	$1.01B	+$136.4M (+15.6%)

3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to MDGL in Q4 2021
Institution	Shares	Value	% of portfolio
Deep Track Capital, LP	500,000	$42.4M	3.13%
Perceptive Advisors LLC	86,400	$7.32M	0.11%
Affinity Asset Advisors, LLC	65,000	$5.51M	2.35%
Jane Street Group, LLC	36,040	$3.05M	0.01%
Altium Capital Management LP	24,000	$2.03M	0.57%
Wit, LLC	17,508	$1.48M	0.03%
Journey Strategic Wealth LLC	13,820	$1.17M	0.12%
Toronto Dominion Bank	10,744	$910.0K	0.00%
HRT Financial LP	9,589	$812.0K	0.00%
Tudor Investment Corp Et Al	8,536	$723.0K	0.01%
MML Investors Services, LLC	5,691	$482.0K	0.00%
Algert Global LLC	5,409	$458.0K	0.06%
Allspring Global Investments Holdings, LLC	4,924	$417.0K	0.00%
Congress Park Capital LLC	2,925	$248.0K	0.12%
Boothbay Fund Management, LLC	2,885	$244.0K	0.01%
Forum Financial Management, LP	2,736	$232.0K	0.01%
PDT Partners, LLC	2,535	$215.0K	0.02%
Walleye Trading LLC	2,520	$214.0K	0.00%
Ensign Peak Advisors, Inc	1,560	$132.0K	0.00%
Aquatic Capital Management LLC	1,100	$93.0K	0.18%
Marshall Wace, LLP	608	$52.0K	0.00%
National Bank of Canada	180	$15.0K	0.00%
Cambridge Trust Co	65	$6.00K	0.00%
CoreCap Advisors, LLC	68	$6.00K	0.00%
CWM, LLC	56	$5.00K	0.00%
Cornerstone Advisory, LLC	50	$4.00K	0.00%
Massmutual Trust Co FSB	7	$1.00K	0.00%
Fortitude Advisory Group L.L.C.	14	$1.00K	0.00%
Covestor Ltd	4	$0	0.00%

Sold out (15)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of MDGL in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Oracle Investment Management Inc	38,500	$3.07M
Point72 Asset Management, L.P.	30,100	$2.40M
Alps Advisors Inc	20,338	$1.62M
Skandinaviska Enskilda Banken AB (publ)	17,800	$1.42M
Martingale Asset Management L P	5,404	$432.0K
Campbell & CO Investment Adviser LLC	5,000	$399.0K
Occudo Quantitative Strategies LP	4,564	$364.0K
Federated Hermes, Inc.	3,303	$264.0K
Principal Financial Group Inc	3,184	$254.0K
LPL Financial LLC	2,813	$224.0K
Group One Trading, L.P.	1,233	$98.0K
Point72 Hong Kong Ltd	932	$74.0K
Penserra Capital Management LLC	380	$30.0K
Geneos Wealth Management Inc.	50	$4.00K
Dark Forest Capital Management LP	17	$1.00K

Not filed for Q4 2021 yet (3)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MDGL in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Marshall Wace North America L.P.	6,274	$501.0K
First Mercantile Trust Co	797	$64.0K
Berman Capital Advisors, LLC	5	$0